Bettina Heidecker

10.3k total citations · 4 hit papers
84 papers, 3.2k citations indexed

About

Bettina Heidecker is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Bettina Heidecker has authored 84 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cardiology and Cardiovascular Medicine, 31 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Bettina Heidecker's work include Viral Infections and Immunology Research (33 papers), Cardiomyopathy and Myosin Studies (21 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers). Bettina Heidecker is often cited by papers focused on Viral Infections and Immunology Research (33 papers), Cardiomyopathy and Myosin Studies (21 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers). Bettina Heidecker collaborates with scholars based in Germany, United States and Switzerland. Bettina Heidecker's co-authors include Joshua M. Hare, Leslie T. Cooper, Peter Ganz, Karin Klingel, Carsten Tschöpe, Sebastian Kelle, Biykem Bozkurt, Alida L.P. Caforio, Sophie Van Linthout and Enrico Ammirati and has published in prestigious journals such as JAMA, Circulation and Nature Communications.

In The Last Decade

Bettina Heidecker

74 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

2020 699 citations Carsten Tschöpe, Leslie T. Cooper et al. profile →
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity

2022 169 citations Claudia Kedor, Helma Freitag et al. Nature Communications profile →
COVID-19, Myocarditis and Pericarditis

2023 87 citations Bettina Heidecker, Leslie T. Cooper et al. profile →
2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis

2024 33 citations Leslie T. Cooper, Bettina Heidecker et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bettina Heidecker Germany	25	1.5k	1.1k	442	433	349	84	3.2k
Giulia d’Amati Italy	45	1.9k 1.3×	2.4k 2.2×	277 0.6×	745 1.7×	716 2.1×	212	6.2k
Richard J. Gumina United States	30	872 0.6×	1.1k 1.0×	737 1.7×	413 1.0×	179 0.5×	90	3.1k
Iddo Z. Ben‐Dov Israel	36	950 0.6×	1.8k 1.6×	150 0.3×	571 1.3×	71 0.2×	133	4.9k
John D. Mitchell United States	32	479 0.3×	1.5k 1.4×	383 0.9×	1.3k 2.9×	296 0.8×	148	7.1k
Ang Li United States	36	477 0.3×	1.1k 1.0×	137 0.3×	457 1.1×	181 0.5×	195	4.6k
Angela J. Fought United States	26	754 0.5×	290 0.3×	244 0.6×	275 0.6×	112 0.3×	105	2.6k
Guy L. Reed United States	38	1.4k 0.9×	973 0.9×	88 0.2×	594 1.4×	252 0.7×	123	4.4k
Patricia K. Nguyen United States	28	878 0.6×	1.1k 1.1×	139 0.3×	761 1.8×	642 1.8×	83	3.1k
Aurélie Fabre Ireland	32	367 0.2×	1.1k 1.0×	128 0.3×	487 1.1×	130 0.4×	166	3.8k
Sabine Pankuweit Germany	36	5.5k 3.8×	1.2k 1.1×	319 0.7×	1.5k 3.5×	396 1.1×	147	6.7k

Countries citing papers authored by Bettina Heidecker

Since Specialization

Citations

This map shows the geographic impact of Bettina Heidecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Heidecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Heidecker more than expected).

Fields of papers citing papers by Bettina Heidecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Heidecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Heidecker. The network helps show where Bettina Heidecker may publish in the future.

Co-authorship network of co-authors of Bettina Heidecker

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Heidecker. A scholar is included among the top collaborators of Bettina Heidecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Heidecker. Bettina Heidecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spethmann, Sebastian, Daniel Messroghli, Katrin Hahn, et al.. (2025). Myocardial Inflammation in Cardiac Transthyretin Amyloidosis: Prevalence and Potential Prognostic Implications. Circulation Heart Failure. 18(2). e012146–e012146. 5 indexed citations

Heidecker, Bettina, Peter Libby, Vassilios S. Vassiliou, et al.. (2025). Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement. European Heart Journal. 46(36). 3518–3531. 9 indexed citations

Knebel, Fabian, Sebastian Spethmann, Daniel Messroghli, et al.. (2024). Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosis. Scientific Reports. 14(1). 10111–10111. 2 indexed citations

Suwalski, Phillip, et al.. (2023). Case report: Magnetocardiography as a potential method of therapy monitoring in amyloidosis. Frontiers in Cardiovascular Medicine. 10. 1224578–1224578. 5 indexed citations

Jurisic, Stjepan, Atanas Todorov, Benedikt Wiggli, et al.. (2023). Long-Term Mortality after New-Onset Atrial Fibrillation in COVID-19. Journal of Clinical Medicine. 12(8). 2925–2925. 2 indexed citations

Thevathasan, Tharusan, Phillip Suwalski, Wolfgang Poller, et al.. (2023). Application of Magnetocardiography to Screen for Inflammatory Cardiomyopathy and Monitor Treatment Response. Journal of the American Heart Association. 12(4). e027619–e027619. 31 indexed citations

Escher, Felicitas, Zehra Karadeniz, Ganna Aleshcheva, et al.. (2023). FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy. Heart. 109(11). 846–856. 1 indexed citations

Heidecker, Bettina, Noa Dagan, Ran D. Balicer, et al.. (2022). Myocarditis following COVID ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. European Journal of Heart Failure. 24(11). 2000–2018. 84 indexed citations

Pietzner, Maik, Robert Lorenz Chua, Eleanor Wheeler, et al.. (2022). ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19. Nature Communications. 13(1). 4484–4484. 15 indexed citations

10.

Kedor, Claudia, Helma Freitag, Lil Meyer‐Arndt, et al.. (2022). A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nature Communications. 13(1). 5104–5104. 169 indexed citations breakdown →

11.

Tscholl, Verena, Andrea Stroux, Philipp Attanasio, et al.. (2021). Benefit of a Wearable Cardioverter Defibrillator for Detection and Therapy of Arrhythmias in Patients with Myocarditis. ESC Heart Failure. 8(4). 2428–2437. 12 indexed citations

12.

Patriki, Dimitri, Leslie T. Cooper, Christine K. Kissel, et al.. (2020). A Prospective Pilot Study to Identify a Myocarditis Cohort who may Safely Resume Sports Activities 3 Months after Diagnosis. Journal of Cardiovascular Translational Research. 14(4). 670–673. 14 indexed citations

13.

Patriki, Dimitri, et al.. (2018). Approximation of the Incidence of Myocarditis by Systematic Screening With Cardiac Magnetic Resonance Imaging. JACC Heart Failure. 6(7). 573–579. 32 indexed citations

14.

Heidecker, Bettina, Victoria Hayes, Sarah Hall, et al.. (2017). High Prevalence and Clinical/Sociodemographic Correlates of Miscarriages Among Flight Attendants. The American Journal of Medicine. 130(12). 1397–1401. 2 indexed citations

15.

Kottwitz, Jan, Deniz Akdiş, Fırat Duru, & Bettina Heidecker. (2016). Severe Hyponatremia Leading to Complete Atrioventricular Block. The American Journal of Medicine. 129(10). e243–e244. 8 indexed citations

16.

Heidecker, Bettina, Alexis L. Beatty, Ruth F. Dubin, et al.. (2015). LOW LEVELS OF GROWTH DIFFERENTIATION FACTOR 11 AND HIGH LEVELS OF ITS INHIBITOR FOLLISTATIN-LIKE 3 ARE ASSOCIATED WITH ADVERSE CARDIOVASCULAR OUTCOMES IN HUMANS. Journal of the American College of Cardiology. 65(10). A999–A999. 7 indexed citations

17.

Kanashiro‐Takeuchi, Rosemeire M., et al.. (2009). Sex‐Specific Impact of Aldosterone Receptor Antagonism on Ventricular Remodeling and Gene Expression after Myocardial Infarction. Clinical and Translational Science. 2(2). 134–142. 63 indexed citations

18.

Do, Tri, et al.. (2008). A rapid method for determining dynamic binding capacity of resins for the purification of proteins. Protein Expression and Purification. 60(2). 147–150. 54 indexed citations

19.

Heidecker, Bettina & Joshua M. Hare. (2007). The use of transcriptomic biomarkers for personalized medicine. Heart Failure Reviews. 12(1). 1–11. 47 indexed citations

20.

Peluso, Paul, David S. Wilson, Huu M. Tran, et al.. (2003). Optimizing antibody immobilization strategies for the construction of protein microarrays. Analytical Biochemistry. 312(2). 113–124. 411 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact